EGFR and neoplasm: Epidemiological research consistently highlights correlations between EGFR mutations and specific patient profiles, including never-smokers, females, Asians, and those with advanced tumor stages (Girard et al., 2011; Russell et al., 2013; Shi et al., 2014).